Highlights Evolent Health, Inc.

Equities

EVH

US30050B1017

Real-time Estimate Cboe BZX Other stock markets 03:07:15 2024-04-29 pm EDT			5-day change	1st Jan Change
27.8 ^USD	+0.56%		-6.60%	-15.56%

Apr. 22	Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target	MT
Mar. 28	Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	Feb. 22	MT
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	Feb. 22	MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	Feb. 22	MT
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	Feb. 22	CI
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Earnings Flash (EVH) EVOLENT HEALTH Posts Q3 EPS $0.30	Nov. 02	MT
Earnings Flash (EVH) EVOLENT HEALTH Reports Q3 Revenue $511M, vs. Street Est of $509.8M	Nov. 02	MT
Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2023 and Full Year 2023	Nov. 02	CI
Evolent Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Earnings Flash (EVH) EVOLENT HEALTH Reports Q2 EPS $0.14, vs. Street Est of $0.15	23-08-02	MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q2 Revenue $469.1M, vs. Street Est of $460.6M	23-08-02	MT
Evolent Health, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023 and Reiterates Earnings Guidance for the Full Year Ending December 31, 2023	23-08-02	CI
Evolent Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Evolent Health Q1 Adjusted Earnings, Revenue Rise	23-05-04	MT
Earnings Flash (EVH) EVOLENT HEALTH Reports Q1 EPS $0.21, vs. Street Est of $0.19	23-05-03	MT
Earnings Flash (EVH) EVOLENT HEALTH Reports Q1 Revenue $427.7M, vs. Street Est of $434.3M	23-05-03	MT
Evolent Health Guides For Q2 Revenue of $455-$470 Million, vs CIQ Analyst Consensus of $465 Million; Full Year 2023 Seen at $1.935-$1.965 Billion, vs Consensus of $1.94 Billion	23-05-03	MT
Evolent Health Announces First Quarter 2023 Results	23-05-03	PR
Evolent Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03	CI
Evolent Health, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023 and for the Year Ending December 31, 2023	23-05-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Evolent Health, Inc.

Equities

EVH

US30050B1017

Highlights

Filters